Volume 15, Number 5—May 2009
Research
Virulent Strain of Hepatitis E Virus Genotype 3, Japan
Table 2
Amino acid position† | Conserved in genotype 3 | Human no. |
Swine no. |
Conserved in genotype 4 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 1 | 2 | 3 | 4 | 5 | ||||
ORF1 | ||||||||||||||||
154 | A | A | T | A | A | T | T | A | T | A | A | T | A | T | T | |
547 | R | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | R | |
598 | R | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | K | |
605 | S | P | P | P | P | P | P | P | P | P | P | P | P | P | P | |
721 | A | T | T | T | T | T | T | T | T | T | T | T | T | T | A | |
807 | A | S | S | S | S | S | S | S | S | S | S | S | S | S | A | |
978 | I | V | V | V | V | V | V | V | V | V | V | V | V | V | V | |
979 | S | K | K | K | K | K | K | K | K | K | K | K | K | K | E | |
1135 | I | T | T | T | T | T | T | T | T | T | T | T | T | T | V | |
1213‡ | V | V | A | A | A | A | A | A | A | A | A | A | A | A | A | |
1246 | Q | H | H | H | H | H | H | H | H | H | H | H | H | H | D | |
1469 |
C |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
S |
C |
|
ORF2 | ||||||||||||||||
98 | P | S | S | P | P | S | S | P | P | P | P | S | P | S | A | |
113 | V/I | T | T | T | T | T | T | T | T | T | T | T | T | T | V | |
660 |
S |
S |
S |
S |
F |
F |
F |
S |
F |
S |
S |
S |
S |
S |
Y |
|
ORF3 | ||||||||||||||||
91 | S | N | N | N | N | N | N | N | N | N | N | N | N | N | S | |
97 | A | A | V | V | V | V | V | V | V | V | V | V | V | V | A | |
98 | P | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | Q | P |
*Eighteen amino acids of 8 human isolates (JIO strain) and 5 swine isolates (swJ19 strain) not shared by other genotype 3 isolates. The 3 at positions 605, 978, and 1213 (boldface) were the same as the corresponding residues in genotype 4 isolates.
†Corresponds to the position in hepatitis E virus (HEV)-US2 (GenBank/EMBL/DDBJ accession no, AF060669) (12).
‡V1213A in the open reading frame (ORF) 1 polyprotein corresponds to V239A in the HEV-US2 genotype 3 isolate helicase domain within ORF1 (online Appendix Figure.
References
- Arankalle VA, Tsarev SA, Chadha MS, Alling DW, Emerson SU, Banerjee K, Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis. 1995;171:447–50.PubMedGoogle Scholar
- Tanaka E, Matsumoto A, Takeda N, Li TC, Umemura T, Yoshizawa K, Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan. J Viral Hepat. 2005;12:439–42. DOIPubMedGoogle Scholar
- Emerson SU, Anderson D, Arankalle A, Meng XJ, Purdy M, Schlauder GG, Hepevirus. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Virus taxonomy: VIIIth report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press; 2004. p. 853–5.
- Abe T, Aikawa T, Akahane Y, Arai M, Asahina Y, Atarashi Y, Demographic, epidemiological, and virological characteristics of hepatitis E virus infections in Japan based on 254 human cases collected nationwide [in Japanese]. Kanzo. 2006;47:384–91. DOIGoogle Scholar
- Inoue J, Nishizawa T, Takahashi M, Aikawa T, Mizuo H, Suzuki K, Analysis of the full-length genome of genotype 4 hepatitis E virus isolates from patients with fulminant or acute self-limited hepatitis E. J Med Virol. 2006;78:476–84. DOIPubMedGoogle Scholar
- Ohnishi S, Kang JH, Maekubo H, Arakawa T, Karino Y, Toyota J, Comparison of clinical features of acute hepatitis caused by hepatitis E virus (HEV) genotypes 3 and 4 in Sapporo, Japan. Hepatol Res. 2006;36:301–7. DOIPubMedGoogle Scholar
- Takahashi M, Nishizawa T, Miyajima H, Gotanda Y, Iita T, Tsuda F, Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J Gen Virol. 2003;84:851–62. DOIPubMedGoogle Scholar
- Takahashi K, Iwata K, Watanabe N, Hatahara T, Ohta Y, Baba K, Full-genome nucleotide sequence of a hepatitis E virus strain that may be indigenous to Japan. Virology. 2001;287:9–12. DOIPubMedGoogle Scholar
- Takahashi K, Kang JH, Ohnishi S, Hino K, Miyakawa H, Miyakawa Y, Full-length sequences of six hepatitis E virus isolates of genotypes III and IV from patients with sporadic acute or fulminant hepatitis in Japan. Intervirology. 2003;46:308–18. DOIPubMedGoogle Scholar
- Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet. 2003;362:371–3. DOIPubMedGoogle Scholar
- Takahashi K, Kitajima N, Abe N, Mishiro S. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology. 2004;330:501–5. DOIPubMedGoogle Scholar
- Erker JC, Desai SM, Schlauder GG, Dawson GJ, Mushahwar IK. A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J Gen Virol. 1999;80:681–90.PubMedGoogle Scholar
- Stoszek SK, Abdel-Hamid M, Saleh DA, El Kafrawy S, Narooz S, Hawash Y, High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg. 2006;100:95–101. DOIPubMedGoogle Scholar
- Stoszek SK, Engle RE, Abdel-Hamid M, Mikhail N, Abdel-Aziz F, Medhat A, Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg. 2006;100:89–94. DOIPubMedGoogle Scholar
- Takahashi K, Okada K, Kang JH, Karino Y, Ichida T, Matsuda H, A lineage of hepatitis E virus within genotype IV, associated with severe forms of hepatitis [in Japanese]. Kanzo. 2005;47:389–90 [cited 2009 Mar 6]. Available from http://www.jstage.jst.go.jp/article/kanzo/46/6/46_389/_article
- van Cuyck H, Fan J, Robertson DL, Roques P. Evidence of recombination between divergent hepatitis E viruses. J Virol. 2005;79:9306–14. DOIPubMedGoogle Scholar
- Ahola T, den Boon JA, Ahlquist P. Helicase and capping enzyme active site mutations in brome mosaic virus protein 1a cause defects in template recruitment, negative-strand RNA synthesis, and viral RNA capping. J Virol. 2000;74:8803–11. DOIPubMedGoogle Scholar
- Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science. 2001;293:1840–2. DOIPubMedGoogle Scholar
- Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998;351:472–7. DOIPubMedGoogle Scholar
- Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. 1998;279:393–6. DOIPubMedGoogle Scholar
- Shrestha MP, Scott RM, Joshi DM, Mammen MP Jr, Thapa GB, Thapa N, Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356:895–903. DOIPubMedGoogle Scholar
Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.